Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cementos Bio-BioXSGO:CEMENTOS 33 Cyclically Adjusted PS Ratio is 1.20 as of Jul. 23, 2026, which is 118% above its 10-year median of 0.55. GuruFocus rates XSGO:CEMENTOS with a GF Score™ of 33/100 and a GF Value™ of CLP742.08 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 325 Building Materials companies, Cementos Bio-Bio ranks worse than 56% on this metric.
The historical rank and industry rank for Cementos Bio-Bio's Cyclically Adjusted PS Ratio or its related term are showing as below:
XSGO:CEMENTOS'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.45 Med: 0.55 Max: 1.26
Current: 1.2
During the past years, Cementos Bio-Bio's highest Cyclically Adjusted PS Ratio was 1.26. The lowest was 0.45. And the median was 0.55.
XSGO:CEMENTOS's Cyclically Adjusted PS Ratio is ranked worse than 56% of 325
companies
in the Building Materials industry
Industry Median: 1.03
vs XSGO:CEMENTOS: 1.20
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Cementos Bio-Bio's adjusted revenue per share data for the three months ended in Dec. 2025 was CLP365.325. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is CLP1,439.82 for the trailing ten years ended in Dec. 2025.
Shiller PE for Stocks: The True Measure of Stock Valuation
Cementos Bio-Bio (XSGO:CEMENTOS) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Cementos Bio-Bio Cyclically Adjusted PS Ratio Related Terms
Cementos Bio-Bio Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Cementos Bio-Bio's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cementos Bio-Bio Cyclically Adjusted PS Ratio Chart
XSGO:CEMENTOS vs CRH, VMC, MLM: Cyclically Adjusted PS Ratio Comparison
For the Building Materials subindustry, Cementos Bio-Bio's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cementos Bio-Bio Cyclically Adjusted PS Ratio vs Building Materials Industry
For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Cementos Bio-Bio's Cyclically Adjusted PS Ratio falls into.
Cementos Bio-Bio Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Cementos Bio-Bio's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 1.20 mean?
Cementos Bio-Bio (XSGO:CEMENTOS) has a Cyclically Adjusted PS Ratio of 1.20 as of Jul. 23, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cementos Bio-Bio and its competitors. This is 118% above median its historical median of 0.55. Over the past decade, Cementos Bio-Bio's Cyclically Adjusted PS Ratio has ranged from 0.45 to 1.26. According to the industry distribution chart, Cementos Bio-Bio ranks #182 out of 325 companies in the Building Materials industry, placing it in the top 56%.
Is Cementos Bio-Bio's Cyclically Adjusted PS Ratio too high?
Cementos Bio-Bio's current Cyclically Adjusted PS Ratio of 1.20 is 118% above median its 10-year median of 0.55. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 1.26. The Building Materials industry median Cyclically Adjusted PS Ratio is 1.03. Cementos Bio-Bio's value of 1.20 is 16.5% above this industry median. Based on the distribution chart, Cementos Bio-Bio ranks #182 out of 325 companies in the Building Materials industry, which is below the industry midpoint. Overall, Cementos Bio-Bio has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's Cyclically Adjusted PS Ratio compare to CRH and VMC?
According to the Building Materials industry distribution chart, Cementos Bio-Bio ranks #182 out of 325 companies for Cyclically Adjusted PS Ratio. This places Cementos Bio-Bio in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.03. Cementos Bio-Bio's value of 1.20 is 16.5% above this benchmark. Historically, Cementos Bio-Bio's own Cyclically Adjusted PS Ratio has ranged from 0.45 to 1.26 over the past decade. While the company's 10-year median is 0.55 vs. the industry median of 1.03, Cementos Bio-Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Building Materials company?
The median Cyclically Adjusted PS Ratio among Building Materials companies is 1.03, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cementos Bio-Bio's current Cyclically Adjusted PS Ratio of 1.20 is 16.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cementos Bio-Bio and its competitors. For the Building Materials industry, the median Cyclically Adjusted PS Ratio is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cementos Bio-Bio's current Cyclically Adjusted PS Ratio is 1.20, which is 118% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Based on GuruFocus' analysis, Cementos Bio-Bio (XSGO:CEMENTOS) is currently considered Significantly Overvalued. The stock's GF Value™ is CLP742.08, compared to a current price of CLP1,730.00 — trading 133.1% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 1.20, which is 118% above median its 10-year median of 0.55 and 16.5% above the Building Materials industry median of 1.03. Cementos Bio-Bio's overall GF Score™ is 33/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current Cyclically Adjusted PS Ratio is 1.20 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?
Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued.
The current stock price of CLP1,730.00 is trading 133.1% above its estimated GF Value™ of CLP742.08.
GuruFocus considers Cementos Bio-Bio to be Significantly Overvalued.
Key valuation signals for XSGO:CEMENTOS:
Cyclically Adjusted PS Ratio: 1.20 (118% above median its 10-year median of 0.55)
GF Value™: CLP742.08 vs. price of CLP1,730.00 (133.1% above fair value)
Industry Position: 16.5% above the Building Materials median (#182 of 325)
No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:CEMENTOS has been successfully added to your 
